Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (391-400 of 522) with videos related to

Pageof 53
Sort By:
The Journal of Urology|September 4, 2019
Racial Discrepancies in Overall Survival among Men Treated with <sup>223</sup>RadiumHanson Zhao, Lauren E Howard, Amanda De Hoedt, et al.
Cancer|June 30, 2017
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health systemAriel A Schulman, Lauren E Howard, Kae Jack Tay, et al.
Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.
The Journal of Urology|September 8, 2020
Clinical Utility of 4Kscore<sup>®</sup>, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate CancerClaire M de la Calle, Vittorio Fasulo, Janet E Cowan, et al.
The Prostate|March 11, 2021
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world populationHanson Zhao, Lauren E Howard, Amanda M De Hoedt, et al.
The Journal of Urology|February 8, 2023
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With ObservationMichael S Leapman, Rong Wang, Stacy Loeb, et al.
Cancer|February 29, 2008
Active surveillance for early-stage prostate cancer: review of the current literatureMarc A Dall'Era, Matthew R Cooperberg, June M Chan, et al.
Urologic Oncology|December 20, 2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRIVinaik Mootha Sundaresan, Lindsey Webb, Maximilian Rabil, et al.
The Prostate|December 14, 2021
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort studySean Kennedy Barlow, Taofik Oyekunle, Jessica L Janes, et al.
Clinical Genitourinary Cancer|July 2, 2019
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?Kae Jack Tay, Thomas J Polascik, Lauren E Howard, et al.
Pageof 53

Showing results (391-400 of 522) with videos related to

Sort By:
Pageof 53
The Journal of Urology|September 4, 2019
Racial Discrepancies in Overall Survival among Men Treated with <sup>223</sup>RadiumHanson Zhao, Lauren E Howard, Amanda De Hoedt, et al.
Cancer|June 30, 2017
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health systemAriel A Schulman, Lauren E Howard, Kae Jack Tay, et al.
Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.
The Journal of Urology|September 8, 2020
Clinical Utility of 4Kscore<sup>®</sup>, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate CancerClaire M de la Calle, Vittorio Fasulo, Janet E Cowan, et al.
The Prostate|March 11, 2021
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world populationHanson Zhao, Lauren E Howard, Amanda M De Hoedt, et al.
The Journal of Urology|February 8, 2023
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With ObservationMichael S Leapman, Rong Wang, Stacy Loeb, et al.
Cancer|February 29, 2008
Active surveillance for early-stage prostate cancer: review of the current literatureMarc A Dall'Era, Matthew R Cooperberg, June M Chan, et al.
Urologic Oncology|December 20, 2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRIVinaik Mootha Sundaresan, Lindsey Webb, Maximilian Rabil, et al.
The Prostate|December 14, 2021
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort studySean Kennedy Barlow, Taofik Oyekunle, Jessica L Janes, et al.
Clinical Genitourinary Cancer|July 2, 2019
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?Kae Jack Tay, Thomas J Polascik, Lauren E Howard, et al.
Pageof 53